JMP Securities Reaffirms “Market Perform” Rating for Simulations Plus (NASDAQ:SLP)

JMP Securities reiterated their market perform rating on shares of Simulations Plus (NASDAQ:SLP) in a research note issued to investors on Wednesday,Benzinga reports.

Other equities analysts have also recently issued reports about the stock. Craig Hallum dropped their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a “buy” rating for the company in a research note on Friday, June 13th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Tuesday, June 3rd. KeyCorp lifted their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 16th. Finally, Wall Street Zen raised shares of Simulations Plus from a “sell” rating to a “hold” rating in a research note on Monday, April 28th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $41.25.

Simulations Plus Stock Down 1.3%

Shares of NASDAQ:SLP opened at $18.08 on Wednesday. Simulations Plus has a 52 week low of $17.97 and a 52 week high of $49.71. The stock has a market capitalization of $363.59 million, a P/E ratio of 51.66 and a beta of 0.97. The firm has a fifty day simple moving average of $30.39 and a two-hundred day simple moving average of $29.94.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 9.18% and a return on equity of 7.86%. The business had revenue of $22.43 million during the quarter, compared to analysts’ expectations of $21.93 million. During the same period last year, the company posted $0.20 EPS. The business’s revenue was up 22.5% on a year-over-year basis. On average, analysts expect that Simulations Plus will post 1.09 earnings per share for the current year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the sale, the director now directly owns 3,344,157 shares of the company’s stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 19.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Simulations Plus

Several large investors have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp raised its holdings in shares of Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after purchasing an additional 427 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Simulations Plus in the 4th quarter valued at about $39,000. Fifth Third Bancorp raised its holdings in shares of Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company’s stock valued at $36,000 after purchasing an additional 375 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock valued at $72,000 after purchasing an additional 764 shares in the last quarter. Finally, AlphaQuest LLC raised its holdings in shares of Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.